| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.38 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.34 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.32 | 3e-18 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.29 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.28 | 8e-16 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.28 | 3e-11 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-14 |